HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

J. Biol. Chem., Vol. 281, Issue 49, 37321-37329, December 8, 2006

This Article Full Text Full Text (PDF) All Versions of this Article: 281/49/37321    most recent M605241200v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Gan, B. Articles by Guan, J.-L. Search for Related Content PubMed PubMed Citation Articles by Gan, B. Articles by Guan, J.-L. Social Bookmarking                      What's this?

Association of Focal Adhesion Kinase with Tuberous Sclerosis Complex 2 in the Regulation of S6 Kinase Activation and Cell Growth^*

From the Department of Molecular Medicine, Cornell University, Ithaca, New York 14853

Tuberous sclerosis complex 1 (TSC1) and TSC2 tumor suppressor proteins have been shown to negatively regulate cell growth through inhibition of the mammalian target of rapamycin (mTOR) pathway. Focal adhesion kinase (FAK) is a cytoplasmic tyrosine kinase that plays a critical role in integrin signaling. Here we identify a novel interaction between FAK and TSC2 and show that TSC2 is phosphorylated by FAK. Furthermore, we show that overexpression of FAK kinase dead mutant inhibits the phosphorylation of ribosomal S6 kinase (S6K) and eukaryotic initiation factor 4E-binding protein-1, two key mTOR (mammalian target of rapamycin) downstream targets, and negatively regulates the cell size and that FAK regulation of S6K phosphorylation is through TSC2. Finally, we provide data that FAK plays a positive role in cell adhesion-induced S6K phosphorylation, whereas TSC2 is required for cell suspension-induced S6K inactivation. Together, these results suggest that FAK might regulate S6K activation and cell size through its interaction with and phosphorylation of TSC2 and also provide a previously unappreciated role of TSC2 in the regulation of mTOR signaling by cell adhesion.

Received for publication, June 1, 2006 , and in revised form, October 16, 2006.

^* This research was supported by National Institutes of Health Grants GM48050 and GM52890 (to J.-L. G.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

¹ To whom correspondence should be addressed. Tel.: 734-615-4936; Fax: 734-615-2506; E-mail: jlguan{at}umich.edu.

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				T. M. Marin, C. F.M.Z. Clemente, A. M. Santos, P. K. Picardi, V. D.B. Pascoal, I. Lopes-Cendes, M. J.A. Saad, and K. G. Franchini Shp2 Negatively Regulates Growth in Cardiomyocytes by Controlling Focal Adhesion Kinase/Src and mTOR Pathways Circ. Res., October 10, 2008; 103(8): 813 - 824. [Abstract] [Full Text] [PDF]

				V. P. Krymskaya Smooth Muscle like Cells in Pulmonary Lymphangioleiomyomatosis Proceedings of the ATS, January 1, 2008; 5(1): 119 - 126. [Abstract] [Full Text] [PDF]